Antihistamines, Amantadine and Evolution of COVID-19
Recruiting
Observational Study
COVID-19
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 140,660 (estimated)
- Sponsor
- Consorci Sanitari de Terrassa · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The rates of symptomatic COVID19 infection, hospital admission among COVID19 cases and survival would be quantified in patiens chronically treated with antihistamines or amantadine, with the aim of determining the role of antihistamines and amantadine in the evolution of COVID19.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria: Patients having chronic treatment with antihistamines or amantadine -
Exclusion Criteria: None
\-
Contacts